Search Results - "BAVARI, Sina"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication by Tsai, Yien Che, Kotiya, Archana, Kiris, Erkan, Yang, Mei, Bavari, Sina, Tessarollo, Lino, Oyler, George A., Weissman, Allan M.

    “…Botulism is characterized by flaccid paralysis, which can be caused by intoxication with any of the seven known serotypes of botulinum neurotoxin (BoNT), all…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus by Jasenosky, Luke D., Cadena, Cristhian, Mire, Chad E., Borisevich, Viktoriya, Haridas, Viraga, Ranjbar, Shahin, Nambu, Aya, Bavari, Sina, Soloveva, Veronica, Sadukhan, Supriya, Cassell, Gail H., Geisbert, Thomas W., Hur, Sun, Goldfeld, Anne E.

    Published in iScience (27-09-2019)
    “…Here, we show that the US Food and Drug Administration-approved oral drug nitazoxanide (NTZ) broadly amplifies the host innate immune response to viruses and…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway by Brahms, Ashwini, Mudhasani, Rajini, Pinkham, Chelsea, Kota, Krishna, Nasar, Farooq, Zamani, Rouzbeh, Bavari, Sina, Kehn-Hall, Kylene

    Published in Journal of virology (01-11-2017)
    “…There is an urgent need for therapeutic development to combat infections caused by Rift Valley fever virus (RVFV), which causes devastating disease in both…”
    Get full text
    Journal Article
  11. 11

    HSPA5 is an essential host factor for Ebola virus infection by Patrick Reid, St, Shurtleff, Amy C., Costantino, Julie A., Tritsch, Sarah R., Retterer, Cary, Spurgers, Kevin B., Bavari, Sina

    Published in Antiviral research (01-09-2014)
    “…•Targeting HSPA5 chaperone activity inhibits EBOV.•EBOV transcript and protein production is impaired in the absence of HSPA5.•Targeting HSPA5 in vivo protects…”
    Get full text
    Journal Article
  12. 12

    IFITM-2 and IFITM-3 but Not IFITM-1 Restrict Rift Valley Fever Virus by Mudhasani, Rajini, Tran, Julie P, Retterer, Cary, Radoshitzky, Sheli R, Kota, Krishna P, Altamura, Louis A, Smith, Jeffrey M, Packard, Beverly Z, Kuhn, Jens H, Costantino, Julie, Garrison, Aura R, Schmaljohn, Connie S, Huang, I-Chueh, Farzan, Michael, Bavari, Sina

    Published in Journal of Virology (01-08-2013)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Ebola virus uses clathrin-mediated endocytosis as an entry pathway by Bhattacharyya, Suchita, Warfield, Kelly L, Ruthel, Gordon, Bavari, Sina, Aman, M. Javad, Hope, Thomas J

    Published in Virology (New York, N.Y.) (25-05-2010)
    “…Abstract Ebola virus (EBOV) infects several cell types and while viral entry is known to be pH-dependent, the exact entry pathway(s) remains unknown. To gain…”
    Get full text
    Journal Article
  15. 15

    Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge by Konduru, Krishnamurthy, Shurtleff, Amy C, Bradfute, Steven B, Nakamura, Siham, Bavari, Sina, Kaplan, Gerardo

    Published in PloS one (13-09-2016)
    “…Ebola virus (EBOV), a member of the Filoviridae that can cause severe hemorrhagic fever in humans and nonhuman primates, poses a significant threat to the…”
    Get full text
    Journal Article
  16. 16

    Advanced antisense therapies for postexposure protection against lethal filovirus infections by Iversen, Patrick L, Bavari, Sina, Warren, Travis K, Warfield, Kelly L, Wells, Jay, Swenson, Dana L, Donner, Kelly S, Van Tongeren, Sean A, Garza, Nicole L, Dong, Lian, Mourich, Dan V, Crumley, Stacy, Nichols, Donald K

    Published in Nature medicine (01-09-2010)
    “…Currently, no vaccines or therapeutics are licensed to counter Ebola or Marburg viruses, highly pathogenic filoviruses that are causative agents of viral…”
    Get full text
    Journal Article
  17. 17
  18. 18

    AVI-7288 for Marburg Virus in Nonhuman Primates and Humans by Heald, Alison E, Charleston, Jay S, Iversen, Patrick L, Warren, Travis K, Saoud, Jay B, Al-Ibrahim, Mohamed, Wells, Jay, Warfield, Kelly L, Swenson, Dana L, Welch, Lisa S, Sazani, Peter, Wong, Michael, Berry, Diane, Kaye, Edward M, Bavari, Sina

    Published in The New England journal of medicine (23-07-2015)
    “…In this study, a potential therapy for Marburg virus infection was assessed by means of a lethal challenge in nonhuman primates, and key pharmacokinetic data…”
    Get full text
    Journal Article
  19. 19
  20. 20